Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. Evidence for multiple sites of insulin resistance.
Open accessThe DOI matches its Crossref record; 63 of the 63 references it cites were found in a registry or an index.
Abstract
The effect of graded, physiologic hyperinsulinemia (+5, +15, +30, +70, +200 microU/ml) on oxidative and nonoxidative pathways of glucose and FFA metabolism was examined in nine lean non-insulin dependent diabetic patients (NIDDM) and in eight age- and weight-matched control subjects. Glucose and FFA metabolism were assessed using stepwise insulin clamp in combination with indirect calorimetry and infusion of [3H]3-glucose/[14C]palmitate. The basal rate of hepatic glucose production (HGP) was higher in NIDDM than in control subjects, and suppression of HGP by insulin was impaired at all but the highest insulin concentration. Glucose disposal was reduced in the NIDD patients at the three highest plasma insulin concentrations, and this was accounted for by defects in both glucose oxidation and nonoxidative glucose metabolism. In NIDDs, suppression of plasma FFA by insulin was impaired at all five insulin steps. This was associated with impaired suppression by insulin of plasma FFA turnover, FFA oxidation (measured by [14C]palmitate) and nonoxidative FFA disposal (an estimate of reesterification of FFA). FFA oxidation and net lipid oxidation (measured by indirect calorimetry) correlated positively with the rate of HGP in the basal state and during the insulin clamp. In conclusion, our findings demonstrate that insulin resistance is a general characteristic of glucose and FFA metabolism in NIDDM, and involves both oxidative and nonoxidative pathways. The data also demonstrate that FFA/lipid and glucose metabolism are interrelated in NIDDM, and suggest that an increased rate of FFA/lipid oxidation may contribute to the impaired suppression of HGP and diminished stimulation of glucose oxidation by insulin in these patients.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Plasma insulin concentrations such as those observed during the present insulin/glucose or glucose infusion studies, are known to completely suppress hepatic glucose production (27); thus, under these conditions, total glucose uptake is equal to exogenous glucose infusion.”
From Differential effects of hyperinsulinemia and carbohydrate metabolism on sympathetic nerve activity and muscle blood flow in humans (1993) · cites this paper as [27]
In the citing paper
“Notably, insulin resistance is also associated with a decreased ability to suppress lipolysis in adipose tissue and altered fatty acid oxidation.50,51”
From The effects of sleep disruption on metabolism, hunger, and satiety, and the influence of psychosocial stress and exercise: A narrative review (2024) · cites this paper as [51]
In the citing paper
“In lean healthy individuals insulin stimulates glucose uptake into skeletal muscle in a dose-dependent manner, with a half-maximal effect (EC50) at a plasma insulin concentration ~60 μU/mL [21].”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [21]
In the citing paper
“Using the gold standard euglycemic hyperinsulinemic clamp technique to quantify insulin-stimulated glucose uptake, they demonstrated that both lean and obese T2DM subjects have marked decrease (>50%) in whole body glucose disposal during the insulin clamp.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [21]
In the citing paper
“During the postabsorptive state, the plasma insulin concentration is low. Since the plasma insulin concentration is the principal factor that restrains lipolysis in adipocytes [21] and stimulates glucose uptake in skeletal muscle [21], during the fasting state, muscle glucose uptake is low and the plasma FFA concentration is elevated.”
From Pathogenesis of insulin resistance in skeletal muscle (2010) · cites this paper as [21]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425
Self-citationRandle, P. J., Garland, P. B., Hales, C. N., & Newsholme, E. A. (1963) · The Lancet · doi:10.1016/s0140-6736(63)91500-9 · Cited by 5,093 · cited 2×
“More than 20 years ago Randle and co-workers introduced the concept of substrate competition, whereby enhanced availability and oxidation of FFA leads to an impairment in glucose oxidation (17).”
BackgroundImmunoassay of insulin with insulin-antibody precipitate
HALES, C., & RANDLE, P. (1963) · Biochemical Journal · doi:10.1042/bj0880137 · Cited by 2,638
The theoretical bases of indirect calorimetry: A review
Ferrannini, E. (1988) · Metabolism · doi:10.1016/0026-0495(88)90110-2 · Cited by 1,580
Self-citationRegulation of hepatic fatty acid oxidation and ketone body production
McGarry, J. D., & Foster, D. W. (1980) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.49.070180.002143 · Cited by 1,460 · cited 1×
“Since CPT I is inhibited by both insulin and malonyl-CoA, which is generated by condensation of acetyl-CoA (56), the insulin-mediated decline in FFA oxidation could have been due to a direct effect of the hormone on CPT I.”
BackgroundRelationship Between Carbohydrate and Lipid Metabolism and the Energy Balance of Heart Muscle
Neely, J. R., & Morgan, H. E. (1974) · Annual Review of Physiology · doi:10.1146/annurev.ph.36.030174.002213 · Cited by 1,261
DeFronzo, R. A., Gunnarsson, R., Björkman, O., Olsson, M., & Wahren, J. (1985) · Journal of Clinical Investigation · doi:10.1172/jci111938 · Cited by 1,167 · cited 2×
“in insulin-mediated glucose metabolism affects both hepatic and peripheral tissues, primarily muscle (1-6).”
BackgroundSelf-citationEffect of fatty acids on glucose production and utilization in man.
Ferrannini, E., Barrett, E. J., Bevilacqua, S., & DeFronzo, R. A. (1983) · Journal of Clinical Investigation · doi:10.1172/jci111133 · Cited by 1,050
Self-citationRadioimmunological determination of human C-peptide in serum
Heding, L. G. (1975) · Diabetologia · doi:10.1007/bf01222104 · Cited by 830
Kolterman, O. G., Gray, R. S., Griffin, J., Burstein, P., Insel, J., Scarlett, J. A., & Olefsky, J. M. (1981) · Journal of Clinical Investigation · doi:10.1172/jci110350 · Cited by 629
Cited by
Items 801–812 of 812
Etude génétique du contrôle glycémique
Bonnefond, A. (2010) · theses.fr (ABES) · doi:10.70675/4e9cd6bdza386z40e4z92faz9ac2313560c5
Étude du rôle de la production hépatique de glucose dans le développement du diabète et de l’obésité
Abdul-Wahed, A. (2012) · theses.fr (ABES) · doi:10.70675/61924053za287z4f04zb650zc51c1916ee64
Dédifférenciation de la cellule bêta pancréatique humaine
Diedisheim, M. (2017) · theses.fr (ABES) · doi:10.70675/9c2e56d4za035z4fa3zafa6z7786e388a812
Gfi1 : a new target for diabetes therapy
Napolitano, T. (2017) · theses.fr (ABES) · doi:10.70675/aaf52a4az6ce1z446czae57z0d918d5706d5
Restaurer la fonction bêta pancréatique de la souris leptine déficiente par la chirurgie bariatrique
Amouyal, C. (2019) · theses.fr (ABES) · doi:10.70675/57e90c8dz951az4b06z95cdzc78f34db6015
Skinner, S. C. (2018) · theses.fr (ABES) · doi:10.70675/bad1111dz9f48z4cb3z82b1z01030b2c1ced
HealthMarkers: Clinical and Metabolic Biomarker Calculation Toolkit
Suleman, S. (2026) · CRAN: Contributed Packages · doi:10.32614/cran.package.healthmarkers
Blicher, L. H., Hodson, L., Smith, K., Hald, B., Andersen, B., & Karpe, F. (2026) · Diabetes · doi:10.2337/db25-0860
Mora‐Gonzalez, D., Moreno‐Cabañas, A., Gonzalez-Garcia, L., Cobo‐Cuenca, A. I., Muñoz‐Turrillas, M. D. C., Mora‐Rodríguez, R., & Morales‐Palomo, F. (2026) · Endocrine Practice · doi:10.1016/j.eprac.2026.06.013
Abdul‐Ghani, M. A., Abu‐Farha, M., Puckett, C., Abdul‐Ghani, T., Baskoy, G., Abdelgani, S., Zaitoon, H., Merovci, A., Adams, J., Triplitt, C., et al. (2026) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2026-006294
Self-citationSasaki, N., Ueno, Y., Ozono, R., Nakano, Y., & Higashi, Y. (2026) · Journal of Hypertension · doi:10.1097/hjh.0000000000004466
Overexpression of glut-1 glucose transporter in human breast cancer an immunohistochemical study
(1993) · doi:10.1002/1097-0142(19931115)72:10 · Cited by 1
Metadata
- Authors
- Groop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E., & DeFronzo, R. A.
- Affiliations
- University of Helsinki (FI)
- Venue
- Journal of Clinical Investigation
- Published
- 1989-07-01
- Volume
- 84
- Issue
- 1
- Pages
- 205-213
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC303971
- OpenAlex
- W1981456793
- Cited by
- 812
- References
- 61
- Citations by year
- 2026: 8 · 2025: 11 · 2024: 28 · 2023: 15 · 2022: 27 · 2021: 30 · 2020: 19 · 2019: 17 · 2018: 25 · 2017: 32 · 2016: 26 · 2015: 22 · 2014: 22 · 2013: 26 · 2012: 26
- FWCI
- 16.26
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- CINECA IRIS Institutial research information system (University of Pisa) (submittedVersion)
- Funders
- National Institutes of Health (AM 24 092)
- Fogarty International Center (F05-TWO-3451)
- National Center for Research Resources (RR 125)
- Ministero dell'Istruzione e del Merito
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diet, Metabolism, and Disease
- Keywords
- type 2 diabetes, insulin resistance, glucose metabolism, free fatty acid metabolism, hepatic glucose production, glucose oxidation, nonoxidative glucose metabolism, fatty acid oxidation, fatty acid re-esterification, hyperinsulinemia, insulin clamp, lipid oxidation
- MeSH terms
- Blood Glucose, C-Peptide, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Female, Glucose, Humans, Insulin, Insulin Resistance, Liver, Male, Middle Aged, Oxidation-Reduction, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.